Celcuity (CELC) Interest & Investment Income (2016 - 2025)
Celcuity (CELC) posted Interest & Investment Income of $4.4 million for Q4 2025, up 20.71% on a QoQ basis from $3.6 million in Q3 2025, and up 43.97% year-over-year from $3.1 million in Q4 2024.
Celcuity (CELC) Interest & Investment Income (2016 - 2025) Analysis & Trends
Celcuity's Interest & Investment Income history runs 10 years deep, the most recent figure standing at $4.4 million for Q4 2025.
- Quarterly Interest & Investment Income rose 43.97% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.3 million (up 4.5% YoY) and the FY2025 annual result came in at $12.3 million, up 4.5% from the prior year.
- Interest & Investment Income was $4.4 million for Q4 2025 at Celcuity, up from $3.6 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.4 million in Q4 2025 and bottomed at $389.0 in Q1 2021.
- A 5-year average of $1.6 million and a median of $1.9 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2021 — Interest & Investment Income plunged 99.39% — and 2023, when it jumped 22588.22%.
- Celcuity's Interest & Investment Income stood at $5459.0 in 2021, then soared by 13379.78% to $735861.0 in 2022, then jumped by 209.58% to $2.3 million in 2023, then surged by 33.97% to $3.1 million in 2024, then jumped by 43.97% to $4.4 million in 2025.
- Business Quant data shows CELC's Interest & Investment Income at $4.4 million in Q4 2025, $3.6 million in Q3 2025, and $1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Celcuity | 3.89 Bn | 3.89 Bn | - | 4.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.39 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 3.05 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 2.28 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 735,861.00 |
| Sep 30, 2022 | 287,495.00 |
| Jun 30, 2022 | 95,646.00 |
| Mar 31, 2022 | 8,159.00 |
| Dec 31, 2021 | 5,459.00 |
| Sep 30, 2021 | 5,612.00 |
| Jun 30, 2021 | 1,803.00 |
| Mar 31, 2021 | 389.00 |